Clarius Group LLC Raises Stake in Corteva, Inc. (NYSE:CTVA)

Clarius Group LLC increased its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 147.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,742 shares of the company's stock after buying an additional 5,211 shares during the period. Clarius Group LLC's holdings in Corteva were worth $550,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. grew its position in shares of Corteva by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 79,174,847 shares of the company's stock worth $4,509,799,000 after acquiring an additional 646,459 shares during the last quarter. Independent Franchise Partners LLP lifted its holdings in Corteva by 51.5% in the fourth quarter. Independent Franchise Partners LLP now owns 16,496,508 shares of the company's stock valued at $939,641,000 after acquiring an additional 5,604,838 shares during the period. Franklin Resources Inc. lifted its holdings in Corteva by 9.2% in the fourth quarter. Franklin Resources Inc. now owns 16,143,025 shares of the company's stock valued at $919,507,000 after acquiring an additional 1,354,418 shares during the period. Capital World Investors increased its position in shares of Corteva by 2,874.6% in the fourth quarter. Capital World Investors now owns 12,812,151 shares of the company's stock valued at $729,780,000 after buying an additional 12,381,436 shares in the last quarter. Finally, Northern Trust Corp increased its position in shares of Corteva by 5.5% in the fourth quarter. Northern Trust Corp now owns 11,648,890 shares of the company's stock valued at $663,521,000 after buying an additional 608,898 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Trading Down 0.7%

CTVA traded down $0.53 during midday trading on Friday, hitting $73.59. The company's stock had a trading volume of 14,522,898 shares, compared to its average volume of 3,386,986. The company has a current ratio of 1.44, a quick ratio of 1.00 and a debt-to-equity ratio of 0.07. The firm has a market cap of $50.20 billion, a P/E ratio of 44.87, a PEG ratio of 1.89 and a beta of 0.75. The firm has a 50-day moving average price of $66.85 and a two-hundred day moving average price of $62.81. Corteva, Inc. has a 52-week low of $50.30 and a 52-week high of $74.84.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $1.13 EPS for the quarter, beating the consensus estimate of $0.88 by $0.25. The company had revenue of $4.42 billion during the quarter, compared to analysts' expectations of $4.56 billion. Corteva had a return on equity of 7.84% and a net margin of 6.77%. The firm's revenue was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.89 EPS. On average, research analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Friday, May 2nd were issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.92%. The ex-dividend date was Monday, June 2nd. Corteva's dividend payout ratio (DPR) is 41.46%.

Analysts Set New Price Targets

CTVA has been the subject of a number of research analyst reports. Jefferies Financial Group restated a "buy" rating on shares of Corteva in a research report on Friday, June 6th. The Goldman Sachs Group initiated coverage on Corteva in a research report on Thursday, March 13th. They issued a "buy" rating and a $71.00 price target for the company. Citigroup raised their price target on Corteva from $75.00 to $78.00 and gave the company a "buy" rating in a research report on Friday, May 9th. UBS Group raised their price target on Corteva from $74.00 to $76.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Finally, Wells Fargo & Company raised their price target on Corteva from $73.00 to $79.00 and gave the company an "overweight" rating in a research report on Monday, May 12th. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Corteva currently has an average rating of "Moderate Buy" and a consensus price target of $71.83.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.